(joburg{etc}) – Elon Musk’s brain-implant venture, Neuralink, has reached a defining moment. For the first time, the company has submitted scientific results from human patients to a respected medical journal, a milestone that signals its entry into serious scientific validation.
The paper, sent to the New England Journal of Medicine, reportedly details data from the first three individuals implanted with Neuralink’s device. It includes safety findings and performance outcomes from ongoing trials at the Barrow Neurological Institute in the United States.
While Neuralink has long generated headlines for its ambitious vision of merging mind and machine, this marks the company’s first move toward peer-reviewed recognition, something that scientists outside Musk’s circle have been waiting for. CONTINUE